Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site - Wikidata - awgldk - TriplyDB

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

http://www.wikidata.org/entity/Q34630104

about

17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and Adipogenesis The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds The role of estrogen and androgen receptors in bone health and disease Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.Sex hormones and glucocorticoids: interactions with the immune system.Modulation by cytokines of glucocorticoid action.Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray.Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling.Local feedback mechanisms in human breast cancer.Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.The menopause and its treatment in perspective.Estrogen modulates NFκB signaling by enhancing IκBα levels and blocking p65 binding at the promoters of inflammatory genes via estrogen receptor-β.Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.Estrogen signaling in metabolic inflammation Estrogens and Androgens in Skeletal Physiology and Pathophysiology.Diversity in the mechanisms of gene regulation by estrogen receptors.Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy.NF-κB addiction and its role in cancer: 'one size does not fit all'.NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial Global gene expression profiling of brown to white adipose tissue transformation in sheep reveals novel transcriptional components linked to adipose remodeling The c-Rel Transcription Factor in Development and Disease.Oestrogen receptor negative breast cancers exhibit high cytokine content Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions.IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells.Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.Rapid activation of nuclear factor κB by 17β-estradiol and selective estrogen receptor modulators: pathways mediating cellular protection.The role of T lymphocytes in bone metabolism.Estrogen signaling multiple pathways to impact gene transcription.Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells.

P2860

Q25256689-4ECC497E-42A1-45A1-8BEB-41D57FD2A4F3 Q26738893-6A41495E-C2B9-4379-8CEF-A2A1F01DEC85 Q26799120-B9E19687-9C80-47B3-8310-A6A0BF828980 Q27008878-67FA26D1-E8AF-4398-AA94-EA3427B8740C Q27016106-5E7106F8-1E94-4A83-86F2-462946546D1B Q27302901-02670515-4734-4967-9448-089356321F2D Q28385120-97B8F89C-CDAF-477B-B575-8E276E8EB097 Q28393372-A29B2F03-7738-4657-BC43-560724647182 Q28396388-2A14FF42-2BAD-499C-A2A4-A2C367FB5287 Q33631538-6EE95437-EE77-4EA3-90CE-1DA0A991C43C Q33632218-1503C740-331F-489A-9271-04E66F9E9AD9 Q33638946-1C16BD98-AE2F-4F6F-A3EB-3C8B99CD6E0F Q33692649-AACFB4CD-6DF9-454E-B401-2577D18A1168 Q33692675-345BC232-C3B3-4F6D-A290-B01E32656DA5 Q33754130-17C6DC41-0DB7-42B1-BC22-CADD55F4E3DA Q33964233-F5612D15-3AC1-4559-BE39-760892F26243 Q34092849-D4CC61AB-EDE0-4591-9275-808033AAC62A Q34197265-CAB657CC-68E5-4B01-8927-A0B289058A1A Q34229929-3D649590-3A14-4E7F-AC33-939FB0A7F216 Q34313766-E2866069-1E44-4560-8891-547953C0CD6D Q34374852-0210A1B0-1534-4406-B9AC-C7E33B1E920D Q34481216-1C20C56D-BBC3-4438-9AFA-843B3E3455B4 Q34543980-BBC83674-6421-4EB4-9FCA-0B48654001A5 Q34561503-F8CB1275-386C-4140-9F55-9ABEE22AEB05 Q35048561-FD6A90C9-CF76-40E6-B037-C112353AD6AA Q35120893-69B56549-AE64-4B72-9610-67BF3A4434C9 Q35469769-9FD439BB-87E2-4A86-A989-E0ACD3FD14DC Q35507040-F29BDDFE-020B-4C9B-98F8-6BADFEFBB24F Q35532336-81AAF7B1-142F-4BF7-8A2B-777B59B23015 Q35556506-ABD8E404-1414-4152-9A42-53FF094A2710 Q35749364-28CEC616-2F12-4992-856C-7CDDE9E5768F Q35749627-0D368D28-A699-4317-8FA1-9AFB3BAB4209 Q35751397-33E4D89E-43DE-413F-BAE1-966FF81509E3 Q35918333-345424AA-754D-41A1-885B-A3CB79ECA790 Q35996338-75F43127-AE26-4B88-9BC5-628158A113AB Q36018567-10741B3C-ED1D-4A9B-BD74-6AE7BA558C83 Q36107305-EC1D6B6C-558E-4771-A2CC-D5CFC7B4E241 Q36324949-1A9BAE5F-04F7-4B7D-96B7-5054C7CA3FE5 Q36499769-799D6036-416D-44FA-A4E6-E6AF2F223DE9 Q36546008-0ACAAFFF-69E4-4BB9-B6E5-BCFD615554E8

P2860

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

http://www.wikidata.org/entity/Q34630104

description

1997 nî lūn-bûn

@nan

1997 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@ast

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@en

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@nl

type

label

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@ast

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@en

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@nl

prefLabel

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@ast

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@en

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@nl

P1433

Q34630104-588F09AD-3DC4-4061-A19A-3AFFDB718841

P1476

Q34630104-2177C452-AC9C-4D41-8E9E-B3D2DAD70F06

P2093

Q34630104-77954F45-0B80-4636-A1CF-060795F44E59

Q34630104-FDC2628D-5921-470E-9345-0470A3323043

P2860

Q34630104-054F0147-A723-4594-8840-4E045EEB7E3E

Q34630104-0D1B176D-C3EF-48DC-85EA-FFACFCA290B7

Q34630104-0E06FD46-8143-4D06-A788-770618A6502D

Q34630104-103B5FDF-4AFB-4384-821B-87B99A4E139B

Q34630104-164B8C4F-3C60-4C9E-A3DC-8CDF87303293

Q34630104-18CEB045-640C-4702-8CAE-B38039ADD16B

Q34630104-20F66687-2D2A-4712-A844-056B483D10D8

Q34630104-22EC737B-B8E0-4C4A-AB7F-5726FE004B2B

Q34630104-28CE4792-6D24-4BE1-8A47-75CF473346C9

Q34630104-304EBA36-7165-44E7-8107-9E1740A13296

P304

Q34630104-B9D44147-69D0-4EAC-892E-E5DA9664C728

P31

Q34630104-667FFD0D-3972-4E43-AD0E-75BD232A268C

P356

Q34630104-40F96ED7-A22C-4C15-B94D-05C5FBFA2CC1

P407

Q34630104-67704F9A-7C6E-47CF-8B3E-7CEA1F34AA94

P433

Q34630104-09586E9C-33C1-4D81-B0C0-0940D7F9A3DF

P478

Q34630104-B7F0DFC2-9999-44A1-BDB2-13C0ED3DA165

P577

Q34630104-A1D35FC8-F665-4238-AF94-141F54B05A8C

P5875

Q34630104-89AF4DBA-AC48-4DF1-9999-24551B371F69

P698

Q34630104-6BEFF087-30B3-42BF-B295-7EBBE2A72FD9

P921

Q34630104-1CD38DB8-1AF2-4002-A7EB-6E42A493006A

Q34630104-5d7b87b5-dc3c-48dd-a30c-235a0ee8eba0

P932

Q34630104-A2AD20AE-D293-4DB2-8EDF-E39486580C7D

P356

P1433

Nucleic Acids Research

P1476

Estrogen receptor impairs inte ...... binding on the NF-kappaB site

@en

P2093

Galien R

http://www.w3.org/2001/XMLSchema#string

Garcia T

http://www.w3.org/2001/XMLSchema#string

P2860

I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6

The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site

Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells

P304

2424-2429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/25.12.2424

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14047820

http://www.w3.org/2001/XMLSchema#string

P698

9171095

http://www.w3.org/2001/XMLSchema#string

P921

P932

146754

http://www.w3.org/2001/XMLSchema#string